Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Interleukin-12 in Treating Patients With Cancer in the Abdomen
| Conditions: | Anal Cancer|Colorectal Cancer|Gallbladder Cancer|Gastric Cancer|Pancreatic Cancer |
| Start Date: | August 1, 1997 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00003046 |
| Study Type: | Interventional |
| Intervention: | Biological: Recombinant Interleukin-12 |
| Study Design: | Allocation: Non-Randomized|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 29 |
| Funded By: | Other|NIH |
| First Received: | November 1, 1999 |
| End Date: | October 1, 2001 |
| Last Updated: | August 4, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
